Immune Cell Profiling During Switching from Natalizumab to Fingolimod Reveals Differential Effects on Systemic Immune-Regulatory Networks and on Trafficking of Non-T Cell Populations into the Cerebrospinal Fluid—Results from the ToFingo Successor Study-Reference-Cited by-同舟云学术

Immune Cell Profiling During Switching from Natalizumab to Fingolimod Reveals Differential Effects on Systemic Immune-Regulatory Networks and on Trafficking of Non-T Cell Populations into the Cerebrospinal Fluid—Results from the ToFingo Successor Study

Published:2018-07-09 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Lohmann Lisa,Janoschka Claudia,Schulte-Mecklenbeck Andreas,Klinsing Svenja,Kirstein Lucienne,Hanning Uta,Wirth Timo,Schneider-Hohendorf Tilman,Schwab Nicholas,Gross Catharina C.,Eveslage Maria,Meuth Sven G.,Wiendl Heinz,Klotz Luisa

Funder

Deutsche Forschungsgemeinschaft

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference43 articles.

1. Weighing in on autoimmune disease: ‘Hub-and-spoke’ T cell traffic in autoimmunity;Steinman;Nat Med,2013

2. Glial influences on BBB functions and molecular players in immune cell trafficking;Lécuyer;Biochim Biophys Acta,2016

3. Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke;Lopes Pinheiro;Biochim Biophys Acta,2016

4. VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells;Schneider-Hohendorf;J Exp Med,2014

5. Long-term follow-up of peripheral lymphocyte subsets in a cohort of multiple sclerosis patients treated with natalizumab;Koudriavtseva;Clin Exp Immunol,2014

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood and CSF findings of cellular immunity in anti-NMDAR encephalitis;International Immunopharmacology;2024-03

2. Multiple faces of multiple sclerosis in the era of highly efficient treatment modalities: Lymphopenia and switching treatment options challenges daily practice;International Immunopharmacology;2023-12

3. Learning CNS immunopathology from therapeutic interventions;Science Translational Medicine;2023-11-08

4. Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis;Neurology and Therapy;2023-06-29

5. The impact of sphingosine-1-phosphate receptor modulators on COVID-19 and SARS-CoV-2 vaccination;Multiple Sclerosis and Related Disorders;2023-01